Clinical Trial Update: Safety and Efficacy of YHD001 in Asthma [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and efficacy of YHD001 in asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• YHD001

Snippet

Sponsor: Yuhan Corporation | Conditions: Asthma | Phase 2 | Status: COMPLETED